 | Up a level |
2017
Roeper, J., Lueers, A., Netchaeva, M., Falk, M., Hallas, C., Tiemann, M., Neemann, N., Heukamp, L., Wesseler, C., Wiest, G. H., Ukena, D., Sackmann, S. and Griesinger, F. (2017). Impact on OS and PFS of 2nd and 3rd generation TKI in EGFR mt1 and ALK1 pts: Results of the NOWEL network. Ann. Oncol., 28. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
2016
Scheel, A. H., Dietel, M., Heukamp, L. C., Joehrens, K., Kirchner, T., Reu, S., Rueschoff, J., Schildhaus, H. U., Schirmacher, P., Tiemann, M., Warth, A., Weichert, W., Fischer, R. N., Wolf, J. and Buettner, R. (2016). Predictive PD-L1 immunohistochemistry for non-small cell lung cancer. Current state of the art and experiences of the first German harmonization study. Pathologe, 37 (6). S. 557 - 568. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1963
2015
Griesinger, F., Cappuzzo, F., Dziadziuszko, R., Reck, M., Lantuejoul, S., Eberhardt, W., Tiemann, M., Heukamp, L., Menon, R. and Heuckmann, J. (2015). Comparison of fluorescence in-situ hybridization and hybrid capture based NGS sequencing for fusion detection in primary tumor specimen of the lung. Oncol. Res. Treat., 38. S. 269 - 271. BASEL: KARGER. ISSN 2296-5262
Griesinger, F., Sebastian, M., Serke, M., Buettner, R., Waller, C., Reinmuth, N., Graeven, U., Lueers, A., Radke, S., Karatas, A., Heukamp, L., Tiemann, M. and Overbeck, T. (2015). Induction therapy with intercalated TKI and chemotherapy in NSCLC with activating EGFR mutation in stages II-IIIB: Neolntercal. Oncol. Res. Treat., 38. S. 140 - 141. BASEL: KARGER. ISSN 2296-5262